Convalescent plasma for COVID-19: Promising, not proven.
| Autor: | Mucha SR; Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic; Clinical Instructor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH., Quraishy N; Section Head Transfusion Medicine, Department of Clinical Pathology, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH quraisn@ccf.org. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cleveland Clinic journal of medicine [Cleve Clin J Med] 2020 Nov 02; Vol. 87 (11), pp. 664-670. Date of Electronic Publication: 2020 Nov 02. |
| DOI: | 10.3949/ccjm.87a.ccc056 |
| Abstrakt: | While promising, convalescent plasma remains experimental and is not proven effective for COVID-19. In addition, many questions remain regarding the accuracy and predictive value of antibody testing of donors and patients, optimal donor selection, optimal timing, and selection of patients most likely to benefit. Until these questions are answered, convalescent plasma should ideally be used in the context of well-designed clinical trials. (Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|